Lifecore Biomedical Inc
LFCR7.240USD
+0.250+3.58%
Market hours （ET）Quotes delayed by 15 min
268.06MMarket Cap
LossP/E TTM
More Details of Lifecore Biomedical Inc Company
Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.
Company Info
Ticker SymbolLFCR
Company nameLifecore Biomedical Inc
IPO dateFeb 15, 1996
CEOMr. Paul Josephs
Number of employees524
Security typeOrdinary Share
Fiscal year-endFeb 15
Address3515 Lyman Boulevard
CityCHASKA
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code55318
Phone19523684300
Websitehttps://www.lifecore.com/
Ticker SymbolLFCR
IPO dateFeb 15, 1996
CEOMr. Paul Josephs
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Thomas (Tom) Salus
Mr. Thomas (Tom) Salus
Chief Legal and Administrative Officer , Corporate Secretary
Chief Legal and Administrative Officer , Corporate Secretary
240.98K
+12.08%
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
133.33K
+249.16%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer, Executive Vice President, Company Secretary
Chief Financial Officer, Executive Vice President, Company Secretary
97.12K
+76.82%
Ms. Katrina Lovas (Kathy) Houde
Ms. Katrina Lovas (Kathy) Houde
Independent Chairman of the Board
Independent Chairman of the Board
79.41K
+32.56%
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
79.17K
+32.69%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
44.06K
+79.44%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
19.51K
--
Ms. Jackie Klecker
Ms. Jackie Klecker
Executive Vice President - Quality and Development Services
Executive Vice President - Quality and Development Services
--
--
Mr. Christopher Kiper
Mr. Christopher Kiper
Independent Director
Independent Director
--
--
Mr. Humberto C. Antunes, M.D.
Mr. Humberto C. Antunes, M.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Thomas (Tom) Salus
Mr. Thomas (Tom) Salus
Chief Legal and Administrative Officer , Corporate Secretary
Chief Legal and Administrative Officer , Corporate Secretary
240.98K
+12.08%
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
133.33K
+249.16%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer, Executive Vice President, Company Secretary
Chief Financial Officer, Executive Vice President, Company Secretary
97.12K
+76.82%
Ms. Katrina Lovas (Kathy) Houde
Ms. Katrina Lovas (Kathy) Houde
Independent Chairman of the Board
Independent Chairman of the Board
79.41K
+32.56%
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
79.17K
+32.69%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
44.06K
+79.44%
Revenue Breakdown
Currency: USDUpdated: Tue, Mar 4
Currency: USDUpdated: Tue, Mar 4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Contract development and manufacturing organization ("CDMO")
17.81M
64.53%
Fermentation
8.52M
30.87%
Olive oil and wine vinegars
1.27M
4.60%
Technology
0.00
0.00%
By RegionUSD
Name
Revenue
Proportion
United States
16.40M
59.42%
Switzerland
6.80M
24.64%
Ireland
1.10M
3.99%
Australia
1.10M
3.99%
Canada
700.00K
2.54%
Other
1.50M
5.43%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Contract development and manufacturing organization ("CDMO")
17.81M
64.53%
Fermentation
8.52M
30.87%
Olive oil and wine vinegars
1.27M
4.60%
Technology
0.00
0.00%
Shareholding Stats
Updated: Sat, Jul 12
Updated: Sat, Jul 12
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Wynnefield Capital, Inc.
12.70%
Legion Partners Asset Management, LLC
11.97%
Greenhaven Road Investment Management, L.P.
9.77%
325 Capital LLC
5.84%
Laughing Water Capital, LP
5.13%
Other
54.59%
Shareholders
Shareholders
Proportion
Wynnefield Capital, Inc.
12.70%
Legion Partners Asset Management, LLC
11.97%
Greenhaven Road Investment Management, L.P.
9.77%
325 Capital LLC
5.84%
Laughing Water Capital, LP
5.13%
Other
54.59%
Shareholder Types
Shareholders
Proportion
Hedge Fund
28.40%
Investment Advisor
23.46%
Investment Advisor/Hedge Fund
18.13%
Individual Investor
2.05%
Research Firm
2.01%
Venture Capital
0.25%
Bank and Trust
0.12%
Insurance Company
0.02%
Other
25.54%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
211
27.29M
73.73%
-2.75M
2025Q1
229
29.94M
81.56%
-2.38M
2024Q4
243
30.30M
82.90%
-2.02M
2024Q3
234
26.35M
84.61%
-494.37K
2024Q2
224
23.91M
77.61%
-4.44M
2024Q1
225
24.56M
80.40%
-3.68M
2023Q4
221
23.64M
77.94%
-3.68M
2023Q3
229
20.71M
68.28%
-6.48M
2023Q2
237
20.72M
68.32%
-8.44M
2023Q1
244
23.24M
76.67%
-6.53M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Wynnefield Capital, Inc.
4.70M
12.7%
--
--
Mar 31, 2025
Legion Partners Asset Management, LLC
4.43M
11.97%
--
--
Mar 31, 2025
Greenhaven Road Investment Management, L.P.
3.62M
9.77%
--
--
Mar 31, 2025
325 Capital LLC
2.16M
5.84%
+1.37M
+172.80%
Mar 31, 2025
Laughing Water Capital, LP
1.90M
5.13%
+321.80K
+20.39%
Feb 18, 2025
David Capital Partners, LLC
1.80M
4.87%
+148.00K
+8.94%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
1.63M
4.41%
+134.35K
+8.97%
Mar 31, 2025
The Vanguard Group, Inc.
1.55M
4.18%
+15.96K
+1.04%
Mar 31, 2025
Geode Capital Management, L.L.C.
750.50K
2.03%
+64.75K
+9.44%
Mar 31, 2025
Morgan Stanley & Co. LLC
617.00K
1.67%
-19.06K
-3.00%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
Invesco Dorsey Wright SmallCap Momentum ETF
0.44%
iShares Micro-Cap ETF
0.05%
WisdomTree US SmallCap Fund
0.03%
Motley Fool Next Index ETF
0.02%
iShares Russell 2000 ETF
0.01%
Global X Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
View more
Invesco Dorsey Wright SmallCap Momentum ETF
Proportion0.44%
iShares Micro-Cap ETF
Proportion0.05%
WisdomTree US SmallCap Fund
Proportion0.03%
Motley Fool Next Index ETF
Proportion0.02%
iShares Russell 2000 ETF
Proportion0.01%
Global X Russell 2000 ETF
Proportion0.01%
ProShares Hedge Replication ETF
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%
ProShares UltraPro Russell2000
Proportion0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
Proportion0.01%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
